Deep Health AI India last traded at ₹1.64 (2026-10-13). Over the past month the stock moved -10.9%, three months the stock moved -28.7%, year the stock moved -62.1%. Its closing range over 52 weeks is ₹1.61 – ₹10.04, with the latest close 83.7% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1993, Deep Diamond India Ltd is in the business of trading Diamond, Jewellery and Pharma products[1]
Business Overview:[1][2] DDIL is engaged in the business of Rough & Polished Diamonds, sale, and trading of diamond studded jewellery & Gold Jewellery, and marketing of pharmaceutical goods and providing consultancy service to the Pharmaceutical industry
In the latest quarter (Jun 2026), Deep Health AI India reported sales of ₹0.45 crore (+200.0%) and net profit of ₹-1.90 crore (-2211.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.45 | -2.06 | -457.78 | -1.90 | -0.13 |
| Mar 2026 | 0.25 | 0.06 | 24.00 | -4.52 | -0.31 |
| Dec 2025 | 0.50 | 0.11 | 22.00 | 3.20 | 0.22 |
| Sep 2025 | 3.35 | 3.23 | 96.42 | 2.53 | 0.18 |
| Jun 2025 | 0.15 | -0.05 | -33.33 | 0.09 | 0.01 |
| Mar 2025 | 0.45 | 0.24 | 53.33 | 0.41 | 0.04 |
| Dec 2024 | 0.00 | -0.15 | – | 0.01 | 0.00 |
| Sep 2024 | 0.30 | 0.13 | 43.33 | 0.15 | 0.02 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -66.3% | -100.0% | -73.5% | -70.6% | +1016.7% | – | -44.4% | +200.0% |
| Operating profit growth | – | -266.7% | – | -122.7% | +2384.6% | – | -75.0% | – |
| Net profit growth | – | -98.1% | – | -69.0% | +1586.7% | +31900.0% | -1202.4% | -2211.1% |
| EPS growth | – | -100.0% | – | -66.7% | +800.0% | – | -875.0% | -1400.0% |
| OPM % | 43.3% | – | 53.3% | -33.3% | 96.4% | 22.0% | 24.0% | -457.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Deep Health AI India reported sales of ₹4.25 crore (+237.3%) and net profit of ₹1.30 crore (+51.2%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4.25 | 3.34 | 78.59 | 1.30 | 0.09 |
| Mar 2025 | 1.26 | 0.45 | 35.71 | 0.86 | 0.27 |
| Mar 2024 | 2.56 | -0.24 | -9.38 | 0.42 | 0.13 |
| Mar 2023 | 7.67 | 1.64 | 21.38 | 1.26 | 0.39 |
| Mar 2022 | 1.39 | 0.01 | 0.72 | 0.20 | 0.06 |
| Mar 2021 | 0.51 | -0.23 | -45.10 | -0.05 | -0.02 |
| Mar 2020 | 0.81 | -0.30 | -37.04 | -0.03 | -0.01 |
| Mar 2019 | 1.25 | -0.29 | -23.20 | -0.02 | -0.01 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -24.7% | -35.2% | -37.0% | +172.5% | +451.8% | -66.6% | -50.8% | +237.3% |
| Operating profit growth | – | – | – | – | +16300.0% | -114.6% | – | +642.2% |
| Net profit growth | – | – | – | – | +530.0% | -66.7% | +104.8% | +51.2% |
| EPS growth | – | – | – | – | +550.0% | -66.7% | +107.7% | -66.7% |
| OPM % | -23.2% | -37.0% | -45.1% | 0.7% | 21.4% | -9.4% | 35.7% | 78.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Deep Health AI India.
Get Free AI Stock Analysis FREE →Deep Health AI India appoints Swami, Dhabriya as independent directors - scanx.trade
Deep Health AI India Limited Board Approves Rights Issue of Up to Rs. 25.00 Crores - scanx.trade
Elegant Floriculture inks MoU with Deep Diamond India for sale of land
Deep Health AI India shares were last quoted at ₹1.64 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Deep Health AI India has a price-to-earnings (P/E) ratio of -34.20 and a price-to-book (P/B) ratio of 0.50. The industry P/E is 55.81.
The 52-week high of Deep Health AI India is ₹10.29 and the 52-week low is ₹1.65.
The market capitalisation of Deep Health AI India is about ₹24.65 crore.
In the latest quarter (Jun 2026), Deep Health AI India reported sales of ₹0.45 crore (+200.0%) and net profit of ₹-1.90 crore (-2211.1%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Deep Health AI India has a 3-year ROE of 10.00%, 3-year profit growth of 73.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 0.03% of Deep Health AI India.
Deep Health AI India belongs to the Diamond & Jewellery sector.